3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net loss $ (904,156) $ (257,947)
Adjustments to reconcile net loss to net cash used in operations    
Non-cash interest expense 331,682
Amortization and depreciation 11,216 162
Gain on fair value change of derivatives (47,610)
Gain on extinguishment of debt (136,675)
Stock compensation expense 395,720
Changes in operating assets and liabilities:    
Inventory (9,250)
Accounts receivable (16,438) (6,186)
Prepaid assets 10,610 9,242
Accounts payable and accrued expenses 91,624 60,619
Accounts payable and accrued expenses, related parties (22,690) 53,732
Net cash used in operating activities (286,717) (149,628)
Cash flows from investing activities:    
Cash acquired in acquisitions 20,574
Net cash used in investing activities 20,574
Cash flows from financing activities:    
Proceeds from sale of common stock 80,000
Proceeds from issuances of convertible notes payable 295,650 50,000
Payments of principal of convertible note payable and notes payable (84,000)
Net cash provided by financing activities 291,650 50,000
Effects of exchange rate on cash and cash equivalents 187 312
Net increase (decrease) in cash and cash equivalents 5,120 (78,742)
Cash and cash equivalents, Beginning of period 50,903 111,035
Cash and cash equivalents, End of period 56,023 32,293
Supplemental disclosure of cash flow information:    
Cash paid for interest 6,755 24,324
Cash paid for income taxes
Schedule of non-cash Investing or Financing Activity:    
Original issue discount included in notes payable 47,350
Issuance of common stock upon convertible note and accrued interest conversion 51,750
Acquisition of Spinus, LLC    
Issuance of Common stock as consideration 250,000
Assumed liabilities 278,779
Accounts receivable (19,054)
Other Assets (250,000)
Goodwill (239,151)
Cash acquired $ 20,574